Mariangela Allocca is an expert in Gastroenterology at IRCCS Ospedale San Raffaele (Italy). As of October 2026, ScienceLeadR ranks Mariangela Allocca in the top 1% of experts worldwide for Inflammatory Bowel Diseases, Gastroenteritis and Colitis. Mariangela Allocca has authored 348 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 9 of them ongoing. SLR score: 1,396 (community average: 125). How the SLR is computed.

LeadR Profile

Mariangela Allocca IRCCS Ospedale San Raffaele Italy
1 396 ScienceLeadR Reputation 1396
Network Map

Gastroenterology

Subspecialties: Hepatology - Public Health - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2002 - 2026

Source: PubMed

IRCCS Ospedale San Raffaele

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Advanced Therapies for the Management of Immune Checkpoint Inhibitor-Induced Colitis.
PMID 42882803 — colitis, safety, neoplasms, multiple chronic conditions, immune checkpoint inhibitors, therapeutics, steroids, infliximab
Cancers (Basel)20260
TREAT-TO-TARGET IN INFLAMMATORY BOWEL DISEASE: PROMISE, PERILS, AND THE PATH FORWARD.
PMID 42829018 — inflammatory bowel diseases, therapeutics
Clin Gastroenterol Hepatol20260
Raising the Bar in Crohn's Disease: Is Transmural Healing Achievable?
PMID 42739179 — crohn disease, inflammatory bowel diseases, therapeutics
Diagnostics (Basel)20260
Intestinal Ultrasound in Inflammatory Bowel Disease: Monitoring Inflammation and Treatment Response.
PMID 42610045 — colitis, inflammatory bowel diseases, therapeutics, colitis, ulcerative
J Inflamm Res20260
Intestinal Ultrasound-Guided Precision Medicine in Inflammatory Bowel Diseases: A Narrative Review.
PMID 42506066 — inflammatory bowel diseases, precision medicine, therapeutics
J Pers Med20260

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

N/A 9
Phase 3 1
Phase 4 1

By status:

Recruiting 8
Completed 2
Not yet recruiting 1

By type:

Observational 6
Interventional 5

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 0
multicentric5to9 1
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

9 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Impact of Exclusion Diet in Addition to Anti TNF Therapy in Crohn s Disease and Ulcerative Colitis a Prospective Randomized Double arm Open label Study
NCT06896305 — eggs, colitis, crohn disease, diet, food, inflammatory bowel diseases, therapeutics, colitis, ulcerative
N/ARecruiting2025
Calculating the LEmann IndeX Using InTEstiNal Ultrasound
NCT06647823 — crohn disease
N/ANot yet recruiting2024
Development of Novel Imaging and Molecular Biomarkers of Fibrosis in Patient With Ulcerative Colitis
NCT06516237 — research design, colitis, fibrosis, elasticity imaging techniques, colon, biopsy, biomarkers, colitis, ulcerative
N/ARecruiting2024
Non invasive Assessment of RECTUM (POUCH) by US (RECT US) in a Cohort of IBD Patients
NCT06407674 — colitis, crohn disease, rectum, proctocolectomy, restorative, colonoscopy, colitis, ulcerative, consent forms
N/ARecruiting2024
VECTORS A Study to Evaluate Transmural Healing as a Treatment Target in Crohn s Disease
NCT06257706 — crohn disease, adrenal cortex hormones, biomarkers, signs and symptoms, therapeutics
Phase 4Recruiting2024

LeadR Networks

Main global connection map